DE68918479T2 - Menschlicher Hitzeschock-Faktor. - Google Patents

Menschlicher Hitzeschock-Faktor.

Info

Publication number
DE68918479T2
DE68918479T2 DE68918479T DE68918479T DE68918479T2 DE 68918479 T2 DE68918479 T2 DE 68918479T2 DE 68918479 T DE68918479 T DE 68918479T DE 68918479 T DE68918479 T DE 68918479T DE 68918479 T2 DE68918479 T2 DE 68918479T2
Authority
DE
Germany
Prior art keywords
heat shock
shock factor
human heat
compounds
pertains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68918479T
Other languages
English (en)
Other versions
DE68918479D1 (de
Inventor
Robert E Kingston
Thomas J Schuetz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/301,417 external-priority patent/US5137805A/en
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of DE68918479D1 publication Critical patent/DE68918479D1/de
Application granted granted Critical
Publication of DE68918479T2 publication Critical patent/DE68918479T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Insects & Arthropods (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Vascular Medicine (AREA)
DE68918479T 1988-03-18 1989-03-17 Menschlicher Hitzeschock-Faktor. Expired - Fee Related DE68918479T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16996588A 1988-03-18 1988-03-18
US07/301,417 US5137805A (en) 1988-03-18 1989-01-25 Method of diagnosing stress condition by specific binding of human heat shock factor

Publications (2)

Publication Number Publication Date
DE68918479D1 DE68918479D1 (de) 1994-11-03
DE68918479T2 true DE68918479T2 (de) 1995-03-02

Family

ID=26865545

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68918479T Expired - Fee Related DE68918479T2 (de) 1988-03-18 1989-03-17 Menschlicher Hitzeschock-Faktor.

Country Status (11)

Country Link
EP (1) EP0333201B1 (de)
JP (1) JPH03503410A (de)
AT (1) ATE112168T1 (de)
AU (1) AU645243B2 (de)
DE (1) DE68918479T2 (de)
DK (1) DK224790A (de)
ES (1) ES2064375T3 (de)
FI (1) FI904564A0 (de)
IE (1) IE62447B1 (de)
PT (1) PT90019B (de)
WO (1) WO1989008661A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009617A1 (en) * 1990-11-26 1992-06-11 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Cell stress transcriptional factors
FI92601C (fi) * 1992-03-11 1994-12-12 Marja Makarow Menetelmä hyötyproteiinien erittämiseksi hiivoista
GB9402857D0 (en) * 1994-02-15 1994-04-06 Isis Innovation Targeting gene therapy
EP0995118A1 (de) * 1997-07-10 2000-04-26 Medical Research Council Chaperonenfragmenten
EP0969100A4 (de) * 1997-09-29 2005-03-16 Hsp Res Inst Inc Verfahren zur untersuchung von expression-induzierenden regulatoren von hitzeschockproteinen
CA3004867C (en) 2008-06-26 2020-09-15 Orphazyme Aps Use of hsp70 as a regulator of enzymatic activity
BR112018070653A2 (pt) 2016-04-29 2019-02-05 Orphazyme As ingrediente farmacêutico ativo, e, composição
JP2024500632A (ja) 2020-11-19 2024-01-10 ゼブラ デンマーク エー／エス アリモクロモルクエン酸塩及びその中間体の調製プロセス

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603106A (en) * 1982-02-22 1986-07-29 The Rockefeller University Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
WO1986003007A1 (en) * 1984-11-16 1986-05-22 Chou Iih Nan Assay for the detection of epigenetic toxic substances

Also Published As

Publication number Publication date
DE68918479D1 (de) 1994-11-03
EP0333201A2 (de) 1989-09-20
IE890817L (en) 1989-09-18
ATE112168T1 (de) 1994-10-15
DK224790D0 (da) 1990-09-18
IE62447B1 (en) 1995-02-08
ES2064375T3 (es) 1995-02-01
FI904564A0 (fi) 1990-09-17
EP0333201B1 (de) 1994-09-28
WO1989008661A1 (en) 1989-09-21
AU3280489A (en) 1989-10-05
JPH03503410A (ja) 1991-08-01
PT90019B (pt) 1994-11-30
AU645243B2 (en) 1994-01-13
DK224790A (da) 1990-11-15
PT90019A (pt) 1990-11-20
EP0333201A3 (en) 1990-05-09

Similar Documents

Publication Publication Date Title
ATE114169T1 (de) Morphogenetisches knochenprotein.
ATE269290T1 (de) Benzoylderivate
FI931370A0 (fi) Kvaeve innehaollande analoger av icke-aromatiska heterocykliska foereningar med en fusionerad ring
NO913785D0 (no) Fremgangsmaate for fremstilling av fibrinogenreseptorantagonister.
ES2103305T3 (es) Produccion de inhibidor de interleuquina-1 humana recombinada.
DE3876400T2 (de) Aminosaeure-imid-derivate, ihre verwendung und diese enthaltende medizinische zusammensetzungen.
ES2076999T3 (es) Peptidos anticoagulantes radiomarcados.
ES2191659T3 (es) Derivados heterociclicos substituidos utiles como inhibidores de la agregacion plaquetaria.
NO871939L (no) Fremgangsmaate for oeket ekspresjon av interleukin-2.
DE68918479D1 (de) Menschlicher Hitzeschock-Faktor.
DK278488A (da) Cycliske peptider med antikoagulerende virkning
DK278588A (da) Cycliske peptider med antikoagulerende virkning
ATE107859T1 (de) Verwendung von antiprogestomimetika zur stimulierung des eisprungs.
FI892222A0 (fi) Peptidalkoholer med antikoagulantverkan.
DE3751362T2 (de) 5-Aryl-3H-1,2,4-triazol-3-one und ihre Verwendung als Antikonvulsiva.
ES2052581T3 (es) Composiciones farmaceuticas.
IT1225483B (it) Protesi ortopedica, particolarmente per la testa del femore.
FI880775A0 (fi) Kraftanlaeggning med foerbraenning av ett braensle i en fluidiserad baedd.
IT8847920A0 (it) Procedimento per la desolforazione chimico-biologica del carbone
SE8201308D0 (sv) Alkylendiaminderivat och forfarande for framstellning derav
ATE44144T1 (de) 6h-dibenzo(b,e)(1,4)oxathiepin-verbindungen.
DE3688742D1 (de) 2,2-diphenoxy-n,n-dimethylaminoaethan zur verbesserung der sauerstoffversorgung des gehirns.
FI893001A0 (fi) Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 1,2-bensisoxazol-3-yl- och 1,2-bensisotiazol -3-ylderivat.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee